China Pharma Holdings CPHI
NYSE CPHI
$0.64 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

China Pharma Holdings (CPHI) Cost of Revenue (2010 - 2026)

Updated

China Pharma Holdings' Cost of Revenue came in at $864,774 for Q2 2026, down 22.3% from $1.11 million a year earlier but up 23.9% from the prior quarter.

Analysis

China Pharma Holdings (CPHI) Cost of Revenue (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, China Pharma Holdings reported Cost of Revenue of $3.45 million, down 34.8% year-over-year; for FY2025, it was $4.28 million, down 34.4% from FY2024.

  • Cost of Revenue has declined in each of the last four years, with a five-year compound annual growth rate of -13.7% (FY2020 to FY2025).
  • Going back by year, Cost of Revenue was $6.51 million in FY2024 (-10.7%), $7.29 million in FY2023 (-15.2%), $8.6 million in FY2022 (-7.5%) and $9.29 million in FY2021 (+4.3%).
  • The five-year range for quarterly Cost of Revenue is $698,049 (Q1 2026) to $2.88 million (Q4 2022).
  • Year-over-year, Cost of Revenue has declined for eight consecutive quarters, with an average decline of 32.8% over the last eight quarters.
  • The fastest year-over-year change in Cost of Revenue over five years came in Q2 2024 (growth of 55.9%), and the weakest in Q3 2025 (a decline of 49.6%).
  • Business Quant data shows CPHI's Cost of Revenue at $698,049 (Q1 2026), $1.08 million (Q4 2025) and $815,871 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 China Pharma Holdings 25.93 Mn 24.81 Mn 83,566.00 864,774.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 864,774.00
Mar 31, 2026 698,049.00
Dec 31, 2025 1.08 Mn
Sep 30, 2025 815,871.00
Jun 30, 2025 1.11 Mn
Mar 31, 2025 1.27 Mn
Dec 31, 2024 1.29 Mn
Sep 30, 2024 1.62 Mn
Jun 30, 2024 1.94 Mn
Mar 31, 2024 1.66 Mn
Dec 31, 2023 2.23 Mn
Sep 30, 2023 2.04 Mn
Jun 30, 2023 1.24 Mn
Mar 31, 2023 1.78 Mn
Dec 31, 2022 2.88 Mn
Sep 30, 2022 2.10 Mn
Jun 30, 2022 1.84 Mn
Mar 31, 2022 1.77 Mn
Dec 31, 2021 2.59 Mn
Sep 30, 2021 2.28 Mn
API Access

China Pharma Holdings Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CPHI&period=max&api_key=YOUR_API_KEY